The effect of desmopressin on platelet aggregation defect in systemic amyloidosis: A preliminary report

European Journal of Haematology

Volumn 56, Issue 5, 1996, Pages 283-286

  Demiroǧlu, Haluk ^a,b   Barişta, Ibrahim ^a   Gürsoy, Murat ^a   Oymak, Oktay ^a   Dündar, Semra ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Amyloidosis; Desmopressin; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; DESMOPRESSIN;

AMYLOIDOSIS; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0029888048     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb00716.x     Document Type: Article

References (24)

1. YOOD RA, SKINNER M, RUBINOW A, TALARICO C, COHEN AS. Bleeding manifestations in 100 patients with amyloidosis. JAMA 1983: 249: 1322-1324.
2. KORSAN-BENGSTEIN K, HJORTH PF, YGGE J. Acquired factor X deficiency in a patient with amyloidosis. Thromb Diath Haemorrh 1962: 7: 558-566.
3. BERNHARDT B, VALLETTA M, BROOK J, LEJNIEKS I. Amyloidosis with factor X deficiency. Am J Med Sci 1972: 264: 411-414.
4. GREIPP PR, KYLE RA, BOWIE EJW. Factor X deficiency in amyloidosis: a critical review. Am J Hematol 1981: 11: 443-450.
5. LEIBMAN H, CHINOWSKY M, VALDIN J, KENOYER G, FEINSTEIN D. Increased fibrinolysis and amyloidosis. Arch Intern Med 1983: 143: 678-682.
6. CHANG JC, KANE KK. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid. Am J Clin Pathol 1984: 81: 382-387.
7. YOOD RA, SKINNER M, RUBINOW A, TALARICO L, COHEN AS. Bleeding manifestations in 100 patients with amyloidosis. JAMA 1983: 249: 1322-1324.
8. MANNUCCI PM, RUGGERI ZM, PARETI FI, CAPITANIO A. DDAVP: A new pharmacological approach to the management of hemophilia and von Willebrand disease. Lancet 1977: 1: 869-872.
9. SAKARIASSEN KS, CATTANEO M, VAN DER BERG A. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood 1984: 64: 229-226.
10. WATSON AJS, KEOGH JAB. Effect of 1-deamino-8-d-arginine vasopressin on the prolonged bleeding time in chronic renal failure. Nephron 1982: 32: 49-52.
11. KOBRINSKY NL, ISRAEL ED, GERRARD JM, et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet 1984: 1: 1145-1148.
12. SCHULMAN S, JOHNSSON H, EGBERG N, BLOMBACK M. DDAVP-induced correction of prolonged bleeding time in patients with congenital platelet function defects. Thromb Res 1987: 45: 165-174.
13. MEEK RL, URIELI SS, BENDITT EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 1994: 91: 3186-3190.
14. SCHLOSSMACHER MG, OSTASZEWSKI BL, HECKER LI, et al. Detection of distinct isoform patterns of the beta-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging 1992: 13: 421-434.
15. DAVIES TA, FINE RE, JOHNSON RJ, et al. Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun 1993: 194: 537-543.
16. BICK RL, ADAMS T, SCHMALHORST WR. Bleeding times, platelet adhesion and aspirin. Am J Clin Pathol 1976: 65: 65-69.
17. THOMAS ME, ORMANI OH, SCRUTTON MC. Some properties of the human platelet vasopressin receptor. Thromb Res 1983: 32: 257-566.
18. YANG X, DISA J, RAO AK. Effect of 1-deamino-8-D-arginine vasopression (DDAVP) on human platelets. Thromb Res 1990: 59: 809-819.
19. KATZEL R, DIETZEL H, SELLE B, TAUBE C. Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro. Z Gesamte Inn Med 1992: 47: 303-307.
20. CATTANEO M, LOMBARDI R, BETTEGA D, LECCHI A, MANNUCCI PM. Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine. Arterioscler Thromb 1993: 13: 393-397.
21. CARR ME, ZEKERT SL. Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uraemia: report of a case. Blood Coagul Fibrinol 1991: 2: 303-308.
22. MALYSZKO J, MALYSZKO JS, AZZADIN A, MYSLIWIEC M, BUCZOKO W. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients. Thromb Res 1992: 68: 303-308.
23. MALYSZKO J, PIETRASZEK M, BUCZKO W, MYSLIWIEC M. Study on mechanisms of haemostatic effects of 1-deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients. Folia Haematol (Leipzig) 1990: 117: 319-324.
24. PETERS JR, GRAHAME-SMITH DG. Human 5-HT receptors: characterization and functional association. Eur J Pharmacol 1980: 68: 243-250.